Commonwealth Equity Services’s Northwest Biotherapeutics NWBO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
– Sell
-45,325
Closed -$25K – 2426
2016
Q3
$25K Buy
45,325
+300
+0.7% +$137 ﹤0.01% 2208
2016
Q2
$26K Hold
45,025
– – ﹤0.01% 2190
2016
Q1
$66K Buy
+45,025
New +$88.8K ﹤0.01% 2109

Other funds holding NWBO

Commonwealth Equity Services's NWBO Position: Q4 2016 in Review

Commonwealth Equity Services sold out of Northwest Biotherapeutics (NWBO) in Q4 2016, closing a stake of 45,325 shares — an estimated $25K sold.

Commonwealth Equity Services first reported a position in NWBO in Q1 2016 and held it in 3 quarters. The position peaked at $66K in Q1 2016. 8 funds tracked by Wall St. Rank hold NWBO as of Q4 2016.

  • Commonwealth Equity Services reported no remaining Northwest Biotherapeutics position as of Q4 2016 after selling out during the quarter.
  • Commonwealth Equity Services sold 45,325 Northwest Biotherapeutics shares in Q4 2016, an estimated $25K.
  • Commonwealth Equity Services first reported a position in Northwest Biotherapeutics in Q1 2016 and held it in 3 quarters.
  • Commonwealth Equity Services's Northwest Biotherapeutics position peaked at $66K in Q1 2016.
  • 8 funds tracked by Wall St. Rank held Northwest Biotherapeutics as of Q4 2016.

Based on Commonwealth Equity Services's 13F filing for Q4 2016, filed 1 Feb 2017.